UNC Genetics and Molecular Biology graduate student Jingyu Zhao in the lab of Sam Lai is a recipient of the 2025 Predoctoral Fellowship in Drug Discovery from the PhRMA Foundation.
Jingyu is researching how to improve chimeric antigen receptor (CAR) T cell therapy, a powerful treatment for blood cancers.
The PhRMA Foundation has just published a video Q&A with Jingyu: In Vivo CAR T Cell Engineering for More Effective, Affordable Cancer Treatment HERE.
Congratulations to Jingyu on this accomplishment!